Requests · The University of Texas Rio Grande Valley School of Medicine

Restoration of the 3% Reductions

Priority 2 · one of 3 items in the The University of Texas Rio Grande Valley School of Medicine's request for 2028-29 · The item begins on page 68 of the request

This is a request, not an appropriation.

What is asked

20282029Two years
All funds$882,000$882,000$1,764,000
Of which general revenue and general revenue-dedicated $882,000$882,000$1,764,000
Positions (full-time equivalents) 8.28.2

How it would be financed

Method of financing, as the request prints it20282029
1 General Revenue Fund$882,000$882,000
Total, as the request prints it$882,000$882,000

Where it would land

The strategies this item would add to, numbered as the request numbers them, beside what each is appropriated in the current budget (2026-27 Act). One column is an appropriation and the other a request made on top of a base request not shown here, so the two are not subtracted.

Strategy Asked 2028Asked 2029Positions Appropriated 2026Appropriated 2027
04-01-02 Cancer Center/Cancer Research $882,000$882,0008.2No strategy matched in the current budget

A strategy is matched by its name. Where none is matched, the strategy may be new, or may be in the current budget under a different name.

After 2029

The agency's estimate203020312032Three years
All funds$882,000$882,000$882,000$2,646,000

In the agency's words: Continued funding of ongoing program maintenance and administrative costs.

The agency's justification

The 3% reduction is being applied to the Cancer Center/Cancer Research non-formula support funding rather than to the School of Medicine and School of Podiatric Medicine items in order to maintain the operating funds essential for continued compliance with accreditation standards, supporting faculty and student success, and sustaining educational quality. While this approach preserves the institutional resources necessary to support accreditation readiness, the reduction will nonetheless affect the Cancer Center’s ability to expand research programs, recruit specialized oncology faculty and researchers, enhance clinical services, and advance development of the region’s first comprehensive academic Cancer Center. Accordingly, UTRGV respectfully requests restoration of the 3% cut to the base budget.

External and internal factors

Additional information is available in the Schedule 9 submission for Cervical Dysplasia and Cancer Immunology Center.

As marked in the request